Updated as of January 31, 2024 It is based on the local time of Seoul, Korea. (UTC+9)

• Thursday, June 20
• Friday, June 21

Date & Time	6/20(Thu) 10:50-11:30	Room	Crystal Ballroom (2F)
To be announced Soonmyung Paik (Yonsei University College of Medicine)

Date & Time	6/20(Thu) 11:30-12:10	Room	Crystal Ballroom (2F)
To be announced Reuben Shaw (Salk Institute for Biological Studies, USA)

Session Title	KCA Golden Jubilee and Global Cancer Network
Date & Time	6/20(Thu) 13:30-14:50	Room	Crystal Ballroom B (2F)
1) KCA - The half of the 100 years Tae You Kim (Seoul National University College of Medicine)
2) JCA walking with Asian researchers Takashi Kohno (National Cancer Center Japan, Japan)
3) CACA's role in National Cancer Control Ying Wang (China Anti-Cancer Association, China)
4) Building an Asian research network through cancer research in Singapore Ashok Venkitaraman (National University of Singapore, Singapore)
5) AACR To be announced (USA)

Session Title	Advanced modeling for predicting and enhancing radiotherapy response
Date & Time	6/20(Thu) 09:00-10:00	Room	Crystal Ballroom B (2F)
1) Considerations in constructing radiotherapy-related learning-based predictive models Hojin Kim (Yonsei University College of Medicine)
2) Next generation radiotherapy using AI, radiomics, modeling WonMo Sung (The Catholic University of Korea College of Medicine)
3) Personalizing radiotherapy for locally advanced non-small cell lung cancer Nitin Ohri (Montefiore Einstein Comprehensive Cancer Center, USA)

Session Title	Hereditary and early-onset cancers
Date & Time	6/20(Thu) 09:00-10:00	Room	Sapphire Ballroom A (3F)
1) Management of hereditary breast and ovarian cancer syndrome - Optimal screening, risk reducing interventions and treatment Sang-Ah Han (Kyung Hee University School of Medicine)
2) Targeting homologous recombination deficiency and mechanisms of resistance Koung Jin Suh (Seoul National University Bundang Hospital)
3) Genomic approaches to identify homologous recombination deficiency Tae-Min Kim (The Catholic University of Korea College of Medicine)

Session Title	Novel therapeutic targets to regulate tumor microenvironment
Date & Time	6/20(Thu) 15:30-17:10	Room	Crystal Ballroom B (2F)
1) Intratumoral regulatory T cells for targeted depletion therapy Su-Hyung Park (Korea Advanced Institute of Science and Technology)
2) Immune regulation by CAFs Rolf Brekken (UT Southwestern, USA)
3) Nutrition-deprived TME can regulate tumor immunity Jae-Hoon Chang (Yeungnam University College of Pharmacy)
4) Senescent cancer stromal cells, a major player, not a player in the back seat Makoto Nakanishi (The University of Tokyo, Japan)

Session Title	Next-generation therapeutics for oncogene-driven cancers
Date & Time	6/20(Thu) 09:00-10:00	Room	Crystal Ballroom A (2F)
1) Next-generation treatments for EGFR-mutant cancers Eun Joo Kang (Korea University College of Medicine)
2) Next-generation HER2-targeted therapy for HER2-amplified cancers Hee Kyung Ahn (Gachon University College of Medicine)
3) Treatment advances in KRAS G12C mutant cancers Sae-Won Han (Seoul National University College of Medicine)

Session Title	Preventing and monitoring Asian cancers
Date & Time	6/20(Thu) 13:30-15:10	Room	Crystal Ballroom A (2F)
1) Environmental risk factors and cancer in Asia Kyoung-Nam Kim (Yonsei University College of Medicine)
2) Cancer screening in China: Current evidence and future challenge Kexin Chen (Tianjin Medical University Cancer Institute & Hospital, China)
3) Personalized cancer prevention : Asian perspectives Daehee Kang (Seoul National University College of Medicine)
4) Primary prevention of gastric cancer in a high-risk area of China Wen-Qing Li (Peking University Cancer Hospital, China)

Session Title	Early cancer detection and cancer prevention in the molecular era
Date & Time	6/20(Thu) 13:30-15:10	Room	Sapphire Ballroom A (3F)
1) Predisposition genes & genetic testing in cancer Sun-Young Kong (National Cancer Center)
2) Family history of cancer as a proxy marker of aggregation of the genetic factors Boyoung Park (Hanyang University College of Medicine)
3) Noninvasive molecular testing for cancer screening Jee-Soo Lee (Seoul National University College of Medicine)
4) Lung cancer screening in Asia Pan-Chyr Yang (National Taiwan University College of Medicine, Taiwan)

Session Title	Oligometastasis
Date & Time	6/20(Thu) 13:30-15:10	Room	Belle-Vue (36F)
1) Suggestion of simpler classification of oligometastases based on systematic review Chai Hong Rim (Korea University College of Medicine)
2) Oligoprogression: past, present, and future Sarah Baker (University of British Columbia, Canada)
3) SABR for oligometastatic cancer: Practical considerations Kyung Hwan Kim (Yonsei University College of Medicine)
4) Oligometastasis: In the era of systemic targeted and immunotherapy Jang Ho Cho (The Catholic University of Korea College of Medicine)

Session Title	Next-generation precision oncology
Date & Time	6/20(Thu) 15:30-17:10	Room	Crystal Ballroom A (2F)
1) K-MASTER Yoon Ji Choi (Korea University College of Medicine)
2) Real-world evidence generated from C-CAT’s big data Takashi Kohno (National Cancer Center Japan, Japan)
3) Whole Genome Sequencing (WGS) implementation in Korea Jeonghwan Youk (Seoul National University College of Medicine)
4) Clinical significance of whole genome sequencing in pediatric cancer Motohiro Kato (The University of Tokyo, Japan)

Session Title	Recent update in pediatric-type sarcoma
Date & Time	6/20(Thu) 15:30-17:10	Room	Sapphire Ballroom A (3F)
1) Update on molecular pathology of pediatric-type sarcoma Jung-Sun Kim (Sungkyunkwan University School of Medicine)
2) New technology in surgical management of pediatric bone tumor Han-Soo Kim (Seoul National University College of Medicine)
3) Updates on the management of pediatric-type sarcoma Jun Ah Lee (National Cancer Center)
4) Update on radiotherapy for pediatric-type sarcoma Seo Hee Choi (Yonsei University College of Medicine)

Session Title	Informatics in oncology 2024
Date & Time	6/20(Thu) 15:30-17:10	Room	Belle-Vue (36F)
1) Integrated proteogenomic characterization of glioblastoma evolution Jong Bae Park (National Cancer Center Graduate School of Cancer Science and Policy)
2) National Bio Big Data Project for precision medicine Eun-Hye Shim (Ministry of Health and Welfare)
3) Federated learning based data analytics platform for precision medicine Hee Hwang (Kakao Healthcare)
4) Health providers’ property right to electronic health records Wonbok Lee (Ewha Womans University)

Session Title	KCA-industry collaboration for future cancer research - New modalities in cancer drug development
Date & Time	6/20(Thu) 13:30-15:10	Room	Sapphire Ballroom B (3F)
1) Leveraging AI in precision medicine and drug discovery through Vertical LLM Jaewoo Kang (Korea University)
2) Harnessing T cell receptors to fight against EGFR mutant lung cancer Byoung Chul Cho (Yonsei University College of Medicine)
3) Precise ADC(Antibody Drug Conjugate) discovery along the bedside Do-Hyun Nam (Samsung Medical Center/AimedBio)
4) Commensal gut microbiota promotes antitumor immunity through activation of iron-sequestration in tumor infiltrating macrophages Garima Shama (ImmunoBiome)

Date & Time	6/20(Thu) 12:20-13:00	Place	Crystal Ballroom A (2F)
SCLC: New treatment paradigms and a glimpse into our treatment options of tomorrow Jii Bum Lee (Yonsei University College of Medicine)

Date & Time	6/20(Thu) 09:00-09:40	Place	Sapphire Ballroom B (3F)
CLDN18.2 targeting treatment for gastric cancer Hyung-Don Kim (University of Ulsan College of Medicine)

Date & Time	6/20(Thu) 15:30-16:10	Place	Sapphire Ballroom B (3F)
Pancreatic cancer: State-of-the-Art Neo/Adjuvant treatment in pancreatic cancer_ Guidance for oncologist TBD

Date & Time	6/21(Fri) 11:00-11:40	Room	Crystal Ballroom (2F)
Evolution of cancer treatment and development of Korean Cancer Association Yung-Jue Bang (Seoul National University College of Medicine)

Date & Time	6/21(Fri) 11:40-12:20	Room	Crystal Ballroom (2F)
How whole genome sequencing can advance precision medicine Emile Voest (Netherlands Cancer Institute, Netherlands)

Session Title	Artificial intelligence for clinical data and big laboratory data
Date & Time	6/21(Fri) 09:00-10:40	Room	Crystal Ballroom B (2F)
1) A system development methodology using protein 3D structure prediction in the field of biomedicine Dongwan Hong (The Catholic University of Korea College of Medicine)
2) Machine leaning on cancer genome and immune data can predict chemotherapy response of upper GI cancers Hidewaki Nakagawa (RIKEN Center for Integrative Medical Sciences, Japan)
3) AI using multiple clinical & imaging data for cancer research Kyu-Hwan Jung (Samsung Advanced Institute for Health Sciences & Technology)
4) AI development and real-world validation through medical imaging standardization Soon Ho Yoon (Seoul National University College of Medicine)

Session Title	Evolution of the WHO classifications of tumors in the molecular era
Date & Time	6/21(Fri) 09:00-10:40	Room	Sapphire Ballroom A (3F)
1) Evolution of the WHO classifications of CNS tumors in the molecular era Se Hoon Kim (Yonsei University College of Medicine)
2) Lymphoma Yoon Kyung Jeon (Seoul National University College of Medicine)
3) Breast tumors - WHO classification and evolving perspectives Puay Hoon Tan (Luma Medical Centre, Singapore)
4) Tumors of the gastrointestinal tracts Kyoung-Mee Kim (Sungkyunkwan University School of Medicine)

Session Title	Perioperative MDT approach for advanced cancer
Date & Time	6/21(Fri) 14:30-16:10	Room	Sapphire Ballroom B (3F)
1) Pathology insights in MDT: Driving precision diagnostics and treatment in cancer care Hye Seung Lee (Seoul National University College of Medicine)
2) The vital importance of the multidisciplinary team win managing lung cancer: A thoracic surgeon’s view Chang Young Lee (Yonsei University College of Medicine)
3) Navigating the cancer journey: The integral role of medical oncology in MDT strategies Sehhoon Park (Samsung Medical Center)
4) Targeting cancer with precision: The integral role of radiation oncology in MDT strategies Sung Uk Lee (National Cancer Center)

Session Title	Treatment approach through tracking ctDNA
Date & Time	6/21(Fri) 16:30-17:30	Room	Crystal Ballroom A (2F)
1) Tumor informed vs. tumor agnostic ctDNA analysis Seung-Tae Lee (Yonsei University College of Medicine)
2) A new era of molecular residual disease: Optimizing perioperative chemotherapy for colorectal cancer Eiji Oki (Kyushu University, Japan)
3) ctDNA monitoring in metastatic cancer Wonyoung Choi (National Cancer Center)

Session Title	Next-generation antibody and cellular therapies in immuno-oncology
Date & Time	6/21(Fri) 09:00-10:40	Room	Crystal Ballroom A (2F)
1) Preclinical study of biparatopic ADC targeting MET Sun Min Lim (Yonsei University College of Medicine)
2) Next-generation antibody development for cancer therapy Ho Min Kim (KAIST)
3) Engineering next generation T cell therapy for cancer Chan Hyuk Kim (Seoul National University)
4) The next generation CAR-T therapies landscape Hyungseok Seo (Seoul National University College of Pharmacy)

Session Title	Understanding and targeting genomic instability
Date & Time	6/21(Fri) 14:30-16:10	Room	Crystal Ballroom A (2F)
1) Whole-genome sequencing reveals the homologous recombination deficiency in human cancer Young Seok Ju (KAIST)
2) Metabolic triggers for cancer genome evolution Ashok Venkitaraman (National University of Singapore, Singapore)
3) In vivo CRISPR therapy targeting cancer-specific genetic alterations Taejoon Kwon (UNIST)
4) Targeting DNA damage repair deficiency in gynaecological cancers David SP Tan (National University Hospital Singapore, Singapore)

Session Title	Functional genomics for novel targets
Date & Time	6/21(Fri) 14:30-16:10	Room	Sapphire Ballroom A (3F)
1) Proteogenomic characterization reveals estrogen signaling as a target for never-smoker lung adenocarcinoma patients without EGFR or ALK alterations Seon-Young Kim (Korea Research Institute of Bioscience and Biotechnology)
2) Emerging therapeutic targets for systemic treatment of advanced gastric cancer In-Ho Kim (The Catholic University of Korea College of Medicine)
3) Single cell-based target identification in cancers Jihwan Park (GIST)
4) Dissecting heterogeneity of histologic patterns reveals a novel target of lung adenocarcinoma ShinYup Lee (Kyungpook National University School of Medicine)

Session Title	국가암진료 가이드라인 사업 성과와 발전 방안
Date & Time	6/21(Fri) 14:30-16:10	Room	Belle-Vue (36F)
1) 암진료가이드라인 사업 추진 현황 곽호신 (국립암센터)
2) 암진료가이드라인 개발 방법론과 검수사항 김수영 (한림의대)
3) 위암 진료 가이드라인 소개 한혜숙 (충북의대)
4) 갑상선암 진료 가이드라인 소개 이은경 (국립암센터)
5) 결장암 진료 가이드라인 소개 곽정면 (고려의대)

Date & Time	6/21(Fri) 14:30-15:45	Room	Crystal Ballroom B (2F)
1) Role of vascular functions in cancer treatment Chang Won Song (University of Minnesota, USA)
2) Vascular regulation of tumor immune exclusion and progression Minah Kim (Columbia University, USA)
3) Hypoxia as a regulator of tumor stroma Kyoung Eun Lee (University of Michigan, USA)

Date & Time	6/21(Fri) 16:30-17:30	Room	Crystal Ballroom B (2F)
1) Mechanisms of oncogenic tyrosine kinase fusion selection in human cancer Taek-Chin Cheong (Boston Children's Hospital and Harvard Medical School, USA)
2) To be announced Duk Ki Kim (Chungnam National University Hospital)
3) Immunotherapy for pancreatic cancer: DNA damage repair deficiency and beyond Wungki Park (Memorial Sloan Kettering Cancer Center, USA)

Date & Time	6/21(Fri) 12:30-13:10	Place	Crystal Ballroom A (2F)
Unlocking the door: A paradigm shift in early-stage NSCLC treatment with pembrolizumab Se-Hoon Lee (Sungkyunkwan University School of Medicine)

Date & Time	6/21(Fri) 09:00-09:20	Place	Sapphire Ballroom B (3F)
A first-line treatment option for locally advanced unresectable or metastatic biliary track cancer Jaekyung Cheon (University of Ulsan College of Medicine)

Date & Time	6/21(Fri) 09:20-10:00	Place	Sapphire Ballroom B (3F)
A journey to the hope of HR+/HER2- EBC&MBC patient: Abemaciclib new data Ji-eun Lee (The Catholic University of Korea College of Medicine)